HaimBio Company
HaimBio is a drug development company. Their flagship product, Starvanip, is a metabolism-based cancer therapy.
Technology:
Others
Industry:
PharmTech
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2011
Employees Number:
11-50
Funding Status:
Seed
Register and Claim Ownership